NCT06405256View on ClinicalTrials.gov

Magnetic Resonance Imaging-guided Adaptive Radiotherapy for Large Brain Metastases

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

January 3, 2020

Primary Completion Date

March 18, 2025

Study Completion Date

March 18, 2025

Conditions
Brain Metastases
Interventions
RADIATION

magnetic resonance imaging-guided adaptive radiotherapy

Stereotactic Radiotherapy (with the prescribed dose of PTV 52-52.5 Gy, 13-15 fractions and Boost (if any) 60Gy, 15 fractions)

Trial Locations (1)

Unknown

RECRUITING

Chinese Academy of Medical Science and Peking Union Medical College, Beijing

All Listed Sponsors
lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER